Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03301623 · ClinicalTrials.gov registry record · NA
Comparative Effectiveness Trial of Communication Strategies in the Management of Chronic Pain
A NA study, sponsored by Cedars-Sinai Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 983
- Enrollment target
NCT03301623 is a NA study that has completed, run by Cedars-Sinai Medical Center. The registered enrollment target is 983 participants.
The verdict
NCT03301623, a NA study, has completed, sponsored by Cedars-Sinai Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 983 participants
- Enrollment target
Study Summary
Investigators will compare Clinical Decision Support (CDS) versus Patient Education and Activation Tools (PEATs) in patients prescribed long-term or multiple opioids to measure outcomes that are important to patients. Primary outcomes are pain interference, physical function, and satisfaction with patient-physician communication. Secondary outcomes are overall Health-Related Quality of Life and high-risk prescribing, including prescriptions over 90 morphine milligram equivalents per day and co-prescribing of benzodiazepines and opioids. Patients in the PEAT arm will receive patient materials during the intervention, developed to engage patients in chronic pain treatment, prior to Primary Care Physician office visits. In the provider-facing CDS arm, PCPs will receive computerized reminders about appropriate opioid use during office visits for enrolled patients. Patients in both groups will receive questionnaires about pain interference, quality of life, and physician-patient communication through the patient portal one month after each visit to their Primary Care Physician (PCP). Investigators will use multi-level regression models to compare the effectiveness of these two communication strategies.
Interventions
- OTHER Clinical Decision Support
- OTHER Patient Education and Activation Tools
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 983 participants |
| Start Date | 2017-11-13 |
| Est. Completion | 2019-12-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03301623
The ClinicalTrials.gov registry entry for NCT03301623 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 983 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Cedars-Sinai Medical Center, which has 339 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Clinical Decision Support is the first listed.
NCT03301623 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03301623 about?
NCT03301623 is a clinical study titled "Comparative Effectiveness Trial of Communication Strategies in the Management of Chronic Pain". Investigators will compare Clinical Decision Support (CDS) versus Patient Education and Activation Tools (PEATs) in patients prescribed long-term or multiple opioids to measure outcomes that are important to patients. Primary outcomes are pain interference, physical function, and satisfaction with p...
What is the current status of trial NCT03301623?
This trial is currently completed. It is a NA study. The enrollment target is 983 participants. The study started on 2017-11-13. Estimated completion is 2019-12-31.
What interventions are being tested in trial NCT03301623?
The interventions under investigation include: Clinical Decision Support (OTHER), Patient Education and Activation Tools (OTHER).
Who is sponsoring clinical trial NCT03301623?
This trial is sponsored by Cedars-Sinai Medical Center, which has 339 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.